Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Healthy Returns: The first drug for a common, deadly liver disease is here – and more are coming
Tags Microsoft Corp Health care industry Healthy Returns
From CNBC.com News
Weight loss drug Wegovy is now approved for heart health — but that won't mean broad insurance coverage just yet
Tags Biotech and Pharmaceuticals Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease
Tags Health & Science Biotechnology Business
From CNBC.com News
Weight Watchers CEO just sent an internal memo to employees as stock crashes, amid debt concerns, Oprah exit
Tags Eli Lilly and Co WW International Inc Health & Science
From CNBC.com News
Experts hesitate on weight loss ETFs amid the obesity drug boom
Tags Investing Health Eli Lilly and Co
From CNBC.com News
Eli Lilly taps Amazon Pharmacy to help deliver weight loss drug Zepbound, other medicines to patients
Tags Companies Breaking news CVS Health Corp
From CNBC.com News
Jim Cramer reviews Citi's European 'Super Seven'
Tags stocks Business News ASML Holding NV
From CNBC.com News
Novo Nordisk's Wegovy wins FDA approval for heart health benefits, in move that could expand insurance coverage
Tags Novo Nordisk A/S Breaking News: Business Social issues
From CNBC.com News
Novo Nordisk CEO says experimental weight loss pill could become a best in class drug
Tags Companies Biotechnology Business
From CNBC.com News
Novo Nordisk market cap surpasses Tesla on new obesity pill trial data
Tags Tesla Inc Europe Markets Markets
From CNBC.com News
Novo Nordisk shares jump 5% on promising weight loss trial results; Eli Lilly dips
Tags Breaking News: Markets Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic slashed the risk of kidney disease progression in trial
Tags Breaking news Companies Health care industry
From CNBC.com News
Cramer says get ready to buy if there's a market sell-off: 'I have my shopping list'
Tags Mad Money Investment strategy Markets
From CNBC.com News
Viking Therapeutics emerges as a strong weight loss drug player — or takeover target
Tags Health care industry Viking Therapeutics Inc Companies
From CNBC.com News
Europe is having its worst earnings season since the onset of Covid — with little hope of a quick turnaround
Tags Europe News Novo Nordisk A/S UniCredit SpA
From CNBC.com News
5 things to know before the stock market opens Thursday
Tags 5 Things to Know Investment strategy Markets
From CNBC.com News
CNBC Daily Open: Markets brace for Fed's key inflation gauge
Tags S&P Global Inc Alphabet Inc Markets
From CNBC.com News
CNBC Daily Open: Wall Street on edge over Fed's key inflation gauge
Tags Economic events Asia Markets Daily Open
From CNBC.com News
The big health decisions Americans will need to make after starting new weight loss drugs
Tags Eli Lilly and Co Health Health & Science
From CNBC.com News
The pet drugs vets are now prescribing look a lot more like human medications
Tickers CATS DOGS PETS
Tags Pharmaceutical industry regulation Pfizer Inc Health care industry
From CNBC.com News
Healthy Returns: The newest treatment use for weight loss drugs? Liver disease
Tags Health & Science Zealand Pharma A/S Eli Lilly and Co
From CNBC.com News
The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons
Tags Europe Economy Health care industry AstraZeneca PLC
From CNBC.com News
Novo Nordisk and Eli Lilly rival soars 26% after promising test results
Tags Markets Breaking News: Markets Zealand Pharma A/S
From CNBC.com News
What you need to know about health insurance coverage for new weight loss drugs, and how to save on costs
Tags Health insurance Employee benefits CNBC Global CFO Council
From CNBC.com News
Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that
Tags Business News Roche Holding AG Novo Nordisk A/S
From CNBC.com News
Eli Lilly says weight loss drug shows promise as treatment for fatty liver disease
Tags Health care industry Companies Breaking news
From CNBC.com News
Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply
Tags Companies Breaking news Mergers
From CNBC.com News
Novo Nordisk beats earnings expectations as Wegovy, Ozempic demand soars
Tags Markets Europe Markets Investment strategy
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Starbucks Corp Boeing Co Apple Inc
From CNBC.com News
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
Tags Biotech and Pharmaceuticals Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.